Clinical trial
Effect of Telmisartan and Captopril on Systemic Inflammation of Patients on Hemodialysis
NCT01271478 is registered in ClinicalTrials.gov with Coordinación de Investigación en Salud, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Telmisartan and Captopril on Systemic Inflammation of Patients on Hemodialysis
- Lead sponsor
- Coordinación de Investigación en Salud, Mexico
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- August 31, 2013
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease, inflammation